Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

May 19, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) has deployed several emergency teams to Niger to contain a meningitis outbreak that has killed 179 people since the beginning of the year. Working closely with Niger’s Ministry of Public Health, MSF teams have vaccinated more than 358,800 people in the most affected areas while continuing to monitor at-risk areas and provide medical care to those affected by the disease. So far, the number of meningitis cases recorded across Niger this year has almost doubled compared to 2016 during the same period.

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most.

April 25, 2017

NEW YORK, APRIL 26, 2017—Replacing the standard vaccines currently recommended by the World Health Organization (WHO)—most of which require refrigeration—with heat-stable versions would save money and increase protection of women, children and babies from deadly diseases like pneumonia, diarrhea, tetanus, measles and yellow fever, according to a study by Doctors Without Borders/Médecins Sans Frontiéres (MSF) and the HERMES Logistics Team (consisting of members from the Johns Hopkins Bloomberg School of Public Health and Pittsburgh Supercomputing Center at Carnegie Mellon Un

March 22, 2017

NEW YORK, MARCH 22, 2017—A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent Doctors Without Borders/Médecins Sans Frontiéres vaccine trial in Niger, published in the New England Journal of Medicine Thursday.

November 16, 2016

Pfizer and GlaxoSmithKline (GSK) should extend their price reduction to all developing countries

September 20, 2016

MSF calls on Pfizer to match GSK’s move and offer the humanitarian community the lowest global price for this lifesaving vaccine

September 19, 2016

“After years of fighting for children caught in crises and desperately in need of the pneumonia vaccine, Doctors Without Borders/Médecins Sans Frontières is relieved to see that GlaxoSmithKline (GSK) finally plans to reduce its vaccine price for humanitarian organizations. GSK is leading the way in this commitment to children who are experiencing the most horrific of circumstances, while Pfizer continues to hide behind excuses and offer only piecemeal approaches to the humanitarian community.

April 27, 2016

MSF hands over global petition as volunteers place 2,500 flowers in front of Pfizer’s headquarters in New York, representing the number of kids who die of pneumonia each day.

April 08, 2016

New York/Lusaka, Zambia—The largest cholera vaccination campaign ever began today in Zambia’s capital, Lusaka. International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working in close collaboration with the Zambian Ministry of Health and the World Health Organization to vaccinate more than half a million people in the next two weeks to curb the outbreak that began in February in the city’s overcrowded township areas.

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

Pages